喵ID:TNZCh9免责声明

Severe Extrapyramidal Symptoms in a Patient with Niemann-Pick Type C Disease After a Long-Acting Injection of Risperidone.

患有 C 型尼曼匹克病的患者在长效注射利培酮后出现严重的锥体外系症状。

基本信息

DOI:
--
发表时间:
2019
影响因子:
2.9
通讯作者:
Jeffrey Stovall
中科院分区:
医学4区
文献类型:
--
作者: Paul A Fuchs;David A Isaacs;Max Schiff;Lindsey Miller;Jeffrey Stovall研究方向: -- MeSH主题词: --
关键词: --
来源链接:pubmed详情页地址

文献摘要

To the Editors: T here has been clear evidence that patients with Parkinson's disease (PD) have an increased risk of developing extrapyramidal side effects (EPS) from antipsychotic medications. However, there is little evidence in the literature on the risk of EPS for less common neurologic disorders, such as Niemann-Pick type C (NPC) disease. Though there have been rare case reports of EPS in these patients after administration of PO antipsychotics, to date, no cases have provided objective evidence of a causal link. Moreover, there are no reports in the literature of patients with NPC disease developing adverse reactions to long-acting injection (LAI) antipsychotic formulations. We present a case of prolonged EPS in a patient with NPC disease after receiving a LAI of an antipsychotic. Verbal consent for publication of this report was obtained from the patient's mother, who is his surrogate decision maker. The patient in our case was a 28-yearold man with a history of schizoaffective disorder who presented with symptoms of dysphagia, dysarthria, and immobility after receiving a LAI of risperidone at an outside hospital on an unknown date before presentation. Outside medical records revealed that he had previously developed catatonic symptoms and difficulty swallowing after initiating oral risperidone. However, these symptoms were attributed to oversedation rather than EPS, so he was continued on risperidone by the outside hospital with eventual administration of a LAI. When he presented to our hospital, he was initially admitted to the neurology
致编辑:已有明确证据表明,帕金森病(PD)患者使用抗精神病药物出现锥体外系副作用(EPS)的风险增加。然而,文献中关于不太常见的神经系统疾病(如尼曼 - 匹克病C型(NPC))出现EPS风险的证据很少。尽管有罕见的病例报告显示这些患者在口服抗精神病药物后出现EPS,但到目前为止,没有病例提供因果关系的客观证据。此外,文献中没有关于NPC病患者对长效注射(LAI)抗精神病制剂产生不良反应的报告。我们介绍了一例NPC病患者在接受抗精神病药物长效注射后出现长时间EPS的病例。本报告的发表已获得患者母亲(作为其代理决策者)的口头同意。我们病例中的患者是一名28岁男性,有分裂情感性障碍病史,在就诊前于一家外院接受利培酮长效注射(具体日期不详)后出现吞咽困难、构音障碍和肢体活动障碍等症状。外院病历显示,他在开始口服利培酮后曾出现紧张症症状和吞咽困难。然而,这些症状被归因于过度镇静而非EPS,因此外院继续让他使用利培酮,最终给予长效注射。当他到我们医院就诊时,最初入住神经内科。
参考文献(5)
被引文献(0)
The plasma phenylalanine/large neutral amino acid ratio: a risk factor for tardive dyskinesia.
血浆苯丙氨酸/大中性氨基酸比率:迟发性运动障碍的危险因素。
DOI:
发表时间:
1989
期刊:
Psychopharmacology bulletin
影响因子:
0
作者:
Richardson,MA;Suckow,R;Whittaker,R;Boggiano,W;Sziraki,I;Kushner,H;Perumal,A
通讯作者:
Perumal,A
Plasma amino acid levels after single-dose aspartame consumption in phenylketonuria, mild hyperphenylalaninemia, and heterozygous state for phenylketonuria.
苯丙酮尿症、轻度高苯丙氨酸血症和苯丙酮尿症杂合状态患者单剂量阿斯巴甜摄入后的血浆氨基酸水平。
DOI:
10.1016/s0022-3476(86)80239-6
发表时间:
1986
期刊:
The Journal of pediatrics
影响因子:
0
作者:
Caballero,B;Mahon,BE;Rohr,FJ;Levy,HL;Wurtman,RJ
通讯作者:
Wurtman,RJ

数据更新时间:{{ references.updateTime }}

Jeffrey Stovall
通讯地址:
--
所属机构:
--
电子邮件地址:
--
免责声明免责声明
1、猫眼课题宝专注于为科研工作者提供省时、高效的文献资源检索和预览服务;
2、网站中的文献信息均来自公开、合规、透明的互联网文献查询网站,可以通过页面中的“来源链接”跳转数据网站。
3、在猫眼课题宝点击“求助全文”按钮,发布文献应助需求时求助者需要支付50喵币作为应助成功后的答谢给应助者,发送到用助者账户中。若文献求助失败支付的50喵币将退还至求助者账户中。所支付的喵币仅作为答谢,而不是作为文献的“购买”费用,平台也不从中收取任何费用,
4、特别提醒用户通过求助获得的文献原文仅用户个人学习使用,不得用于商业用途,否则一切风险由用户本人承担;
5、本平台尊重知识产权,如果权利所有者认为平台内容侵犯了其合法权益,可以通过本平台提供的版权投诉渠道提出投诉。一经核实,我们将立即采取措施删除/下架/断链等措施。
我已知晓